Why Government-Funded Companies Overlook the R&D Tax Credits

Many companies that participate in SBIR and STTR programs leave potential R&D tax credits on the table. By definition, these companies perform qualified research activities—developing new or improved technologies, resolving technical uncertainty, and engaging in iterative experimentation.

But many companies either do not pursue the credit or take an overly conservative position that significantly limits the benefit. This is rarely due to actual ineligibility. Instead, it stems from confusion in how companies interpret and apply the rules governing “funded research.”

To maximize tax incentives while maintaining compliance, it is critical for companies (and their advisors) to understand the complex dynamics between funded research, intellectual property, and the R&D itself.

One reason many companies underutilize the R&D credit is confusion with the funded research exclusion under Internal Revenue Code Section 41(d)(4)(H) FUNDED RESEARCH. This provision excludes from credit eligibility “any research to the extent funded by any grant, contract, or otherwise by another person (or governmental entity).”

SBIR and STTR recipients often incorrectly assume that this exclusion means that government-funded projects do not qualify because someone else is paying for the work. In reality, there is more nuance to the legislation. The rules are designed to prevent a company from claiming a tax credit on expenses that have already been reimbursed, not to eliminate eligibility for entire projects.

Despite this, many companies dismiss potential credit opportunities without evaluating whether some or all their work falls outside the funded research exclusion.

Whether research is considered “funded” depends largely on the terms of the contract. Rather than assuming that all government-funded work is disqualified from the R&D credit, companies should undertake a detailed review of the contract terms to determine which, if any, expenses qualify.

In most cases, the analysis comes down to two factors, “rights” and “risk”:

A company generally needs to retain meaningful rights to the research results in order to claim the related R&D expenses. This does not mean the company must have exclusive ownership of the intellectual property.

For example, many government contracts allow the government certain usage rights while still permitting the company to use and commercialize the technology it develops. In those situations, the company often satisfies the rights requirement.

The next question is who bears the financial risk.

If a contract guarantees payment regardless of the project’s outcome, the research is more likely to be considered funded. This is common in Time & Materials (T&M) and Level of Effort (LoE) contracts.

On the other hand, when a company must absorb cost overruns or is only profitable if the work is completed efficiently, it assumes more financial risk. Fixed-price contracts are a common example. In these cases, the work is more likely to qualify for the R&D tax credit.

Some contracts share risk between the parties. Contracts such as Cost-Plus-Fixed-Fee (CPFF), Cost-Plus-Award-Fee (CPAF), or agreements that include upfront payments may result in a portion of the research being treated as funded and another portion as non-funded.

Because of this, eligibility is not always an all-or-nothing determination.

These same considerations also exist beyond the SBIR/STTR programs. For other Tier 1 government contracts, along with companies who subcontract to Tier 1 contractors, these same requirements will often flow through the different Terms and Conditions. Even with contracts between businesses, the rights and risk profile will determine who (if anyone) gets to claim the research expenditures for their R&D credit.

The interaction between rights and risk can be complex. A company may retain intellectual property rights but have little financial risk, or vice versa. In some situations, neither party meets all the requirements necessary to claim the related R&D expenses.

Because of this complexity, a detailed contract review is essential to determine eligibility for R&D tax credits.

Another source of confusion about eligibility for R&D tax credits can be a disconnect between program intent versus the terms of the contract.

The SBIR and STTR programs are intended to promote innovation and eventual commercialization of technologies that would otherwise potentially not be investigated. In many cases, companies retain ownership of the technology they develop and are expected to bring those innovations to market, with the government sometimes supporting these efforts through Phase II and Phase III contracts.

But this intent does not determine tax credit eligibility, which is based entirely on contract mechanics and the core R&D credit qualification guidelines.  From a program perspective, the work may be entrepreneurial and risk-driven, but from a tax perspective, eligibility depends on how risk and ownership are reflected in the agreement.

An additional factor in why companies often fail to claim R&D tax credits is that the funded research exclusion has long been an area of IRS focus with both audits and court cases. As a result, companies and their advisors will often take a conservative approach to avoid potential disputes.

While this caution is understandable, it will also result in missed opportunities. In many cases, the issue is not whether a company qualifies, but whether the analysis and documentation are sufficiently robust to support the position.

Companies or advisors that do not have experience navigating these rules may choose not to pursue the credit rather than invest in the necessary analysis.

An additional hurdle for companies trying to claim R&D tax credits is accurately identifying and separating qualifying costs.

The rules require taxpayers to exclude expenses that are directly reimbursed while allowing inclusion of costs that are internally funded. In practice, this requires:

Many early-stage or growth-stage companies who are participants in SBIR/STTR Phase I programs do not have systems in place to perform this level of cost accounting, nor is it required by the government. As a result, many companies default to excluding entire projects rather than implementing an allocation methodology such as time tracking.

A final contributing factor is the lack of specialized expertise. The interaction between R&D credit rules and government funding structures is highly technical and fact-specific.

General tax advisors can appropriately flag the risks associated with funded research but may not have the expertise or time to perform the detailed contract and cost analysis required to identify eligible expenses within a broader project.

As a result, companies may receive high-level guidance that leads to conservative outcomes without fully understanding the range of potential positions available.

For SBIR and STTR recipients, the key to unlocking R&D tax credits is a more complete evaluation that looks not only at whether funding was received, but at how that funding interacts with their contractual obligations, financial risk, and rights to the underlying technology.

A comprehensive evaluation typically includes:

When these steps are taken, many companies find that they have a meaningful credit opportunity, even in the presence of government funding.

If your company has received SBIR or STTR funding, performs work under government contracts, or conducts research on behalf of customers, it’s important to understand how funded research rules apply to your specific situation.

Contact one of our R&D tax credit professionals today for a contract review and eligibility assessment. Our team can help you identify qualifying research expenses, navigate funded research rules, and maximize the value of your available tax credits.